quinazolines has been researched along with hyaluronoglucosaminidase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chariot, A; Shostak, K | 1 |
| Petkova, A; Schätzlein, AG; Soundararajan, R; Uchegbu, IF; Wang, G | 1 |
1 review(s) available for quinazolines and hyaluronoglucosaminidase
| Article | Year |
|---|---|
EGFR and NF-κB: partners in cancer.
Topics: Animals; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Neoplasms; NF-kappa B; Protein Kinase Inhibitors; Proteins; Quinazolines; Signal Transduction | 2015 |
1 other study(ies) available for quinazolines and hyaluronoglucosaminidase
| Article | Year |
|---|---|
Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hyaluronoglucosaminidase; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polymers; Quinazolines; Rats; Solubility; Xenograft Model Antitumor Assays | 2020 |